Early Outcomes from the Optimize PRO TAVR Care Pathway Evolut FX System Addendum Study
Hemal Gada, M.D.1, Steven J. Yakubov, M.D., MSCAI2, Ramzi F. Khalil, M.D., FSCAI3, Stanley J. Chetcuti, M.D., FSCAI4, G. Michael Deeb, M.D.4, Adam Greenbaum, M.D.5, David Lorenz, M.D.6, Robert D Jumper, M.D.6, Ibrahim Sultan, M.D.7, Paul Dennis Mahoney, M.D., FSCAI8, Joseph R. Newton9, Deepak R. Talreja, M.D.9, Mustafa I. Ahmed, M.D.10, Joshua D. Rovin, M.D.11, Lang Lin, M.D.11, Paul Sorajja, M.D., FSCAI12, Paige Tracy, Ph.D.13, Yu Jung Yeh, M.S.13 and Kendra J. Grubb, M.D.5, (1)University of Pittsburgh Medical Center Pinnacle Health, Wormleysburg, PA, (2)OhioHealth Heart & Vascular Physicians, Columbus, OH, (3)Allegheny General Hospital, Pittsburgh, PA, (4)The University of Michigan, Ann Arbor, MI, (5)Emory University, Atlanta, GA, (6)Saint Vincent’s Medical Center, Bridgeport, CT, (7)University of Pittsburgh Medical Center, Pittsburgh, PA, (8)ECU Health, Greenville, NC, (9)Sentara Health Systems, Norfolk, VA, (10)University of Alabama at Birmingham Medicine, Birmingham, AL, (11)Morton Plant Hospital, Clearwater, FL, (12)Minneapolis Heart Institute® - Abbott Northwestern Hospital, Minneapolis, MN, (13)Medtronic, Minneapolis, MN